Showing results (11-20 of 91) with videos related to

Sort By:
Pageof 10
STAR Protocols|October 14, 2022
Isolation, culture, and immunophenotypic analysis of bone marrow HSPCs from patients with myelodysplastic syndromesIrene Ganan-Gomez, Karen Clise-Dwyer, Simona Colla
Haematologica|September 21, 2004
The RANK/RANK ligand system is involved in interleukin-6 and interleukin-11 up-regulation by human myeloma cells in the bone marrow microenvironmentNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Leukemia & Lymphoma|December 29, 2004
Angiopoietin-1 and myeloma-induced angiogenesisNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Haematologica|February 16, 2005
Lack of receptor activator of nuclear factor-kB ligand (RANKL) expression and functional production by human multiple myeloma cellsNicola Giuliani, Simona Colla, Francesca Morandi, et al.
Bioinformatics (Oxford, England)|September 9, 2022
A machine learning-based method for automatically identifying novel cells in annotating single-cell RNA-seq dataZiyi Li, Yizhuo Wang, Irene Ganan-Gomez, et al.
Haematologica|May 12, 2004
e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?Simona Colla, Gabriella Sammarelli, Simone Voltolini, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Targeting MCL1-driven anti-apoptotic pathways to overcome hypomethylating agent resistance in RAS -mutated chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Feiyang Ma, Natthakan Thongon, et al.
Nature Communications|March 19, 2024
Hematopoietic stem cells with granulo-monocytic differentiation state overcome venetoclax sensitivity in patients with myelodysplastic syndromesJuan Jose Rodriguez-Sevilla, Irene Ganan-Gomez, Feiyang Ma, et al.
Biorxiv : the Preprint Server for Biology|October 9, 2023
IL-1β-mediated inflammatory signaling drives ineffective erythropoiesis in early-stage myelodysplastic syndromesVera Adema, Irene Ganan-Gomez, Feiyang Ma, et al.
Cell Reports. Medicine|May 23, 2024
Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemiaGuillermo Montalban-Bravo, Natthakan Thongon, Juan Jose Rodriguez-Sevilla, et al.
Pageof 10